Aptevo Therapeutics (APVO) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-18.04
-12.19
-6.35
-0.5

Details

Expected EPS
-10.77
Actual EPS
-9.95
Surprise EPS
0.82
Surprise Percent
+7.61%

Description

Aptevo Therapeutics (APVO) has reported earnings of -9.95 per share for Q2 2024.

0 Comments

Share your thoughts